Effect of Beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction

The American Journal of Cardiology
Padmini VaradarajanRamdas G Pai

Abstract

Chronic volume overload from chronic severe mitral regurgitation (MR) results in neuroendocrine activation similar to the heart failure syndrome despite normal left ventricular (LV) ejection fraction (EF). Hence, the hypothesis that beta-blocker (BB) therapy may have a beneficial effect in these patients was tested using a large observational cohort. Our echocardiographic database was searched for patients with severe MR and normal LVEF. Full chart reviews were conducted for clinical and pharmacologic data. Survival was analyzed as a function of BB therapy. The search produced 895 patients aged 68 +/- 17 years, 44% men, with LVEF 66 +/- 7%. Of these, 32% were on BB therapy. Use of a BB was associated with a significantly decreased mortality hazard of 0.62 (95% confidence interval 0.46 to 0.83, p = 0.002), which was unchanged after adjusting for age, gender, LVEF, coronary artery disease, diabetes mellitus, hypertension, and cardiac valve surgery. The independent beneficial effect of BBs was seen in patients with or without coronary artery disease, those with or without hypertension, and patients managed both medically and surgically. In conclusion, use of BB therapy was associated with a significant independent survival benefit...Continue Reading

References

Jan 13, 2006·The Journal of Toxicological Sciences·Satoru TanakaTakemi Yoshida

❮ Previous
Next ❯

Citations

Nov 26, 2009·Current Treatment Options in Cardiovascular Medicine·Blase A Carabello
Sep 18, 2010·Circulation. Cardiovascular Imaging·Daniel B EnnisRalph A H Stewart
Aug 29, 2014·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hidehiro KanekoTakeshi Yamashita
May 2, 2014·The American Journal of the Medical Sciences·Justin Barnes, Louis J DellʼItalia
May 26, 2012·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Ramdas G Pai
Jun 9, 2012·Mayo Clinic Proceedings·Muaz M AbudiabWilliam K Freeman
Mar 1, 2012·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·Sonya G GordonMatthew W Miller
Sep 8, 2010·The American Journal of Cardiology·Francesco MaffessantiMauro Pepi
Jul 24, 2012·Journal of the American College of Cardiology·Mustafa I AhmedLouis J Dell'Italia
Jul 19, 2013·Circulation. Heart Failure·Jeffrey S Borer
Apr 17, 2013·Circulation·Blase A Carabello
May 29, 2016·Annals of Biomedical Engineering·Daniella EspirituMuralidhar Padala
Mar 29, 2011·Hospital Practice·Mehrdad GhoreishiJames S Gammie
May 28, 2016·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Yoshio Yasumura
Mar 2, 2019·Current Hypertension Reports·Vasiliki KatsiDimitrios Tousoulis
Jun 20, 2019·Journal of Clinical Medicine·Benedetta PorroPaolo Poggio
Sep 16, 2015·Circulation·Jeffrey S Borer, Abhishek Sharma
Dec 6, 2017·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Padmini Varadarajan, Ramdas G Pai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.